MainStreet Investment Advisors LLC lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 1.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,659 shares of the healthcare conglomerate’s stock after selling 203 shares during the quarter. MainStreet Investment Advisors LLC’s holdings in UnitedHealth Group were worth $5,392,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of UNH. NewSquare Capital LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in UnitedHealth Group during the fourth quarter valued at about $26,000. Hurley Capital LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at about $28,000. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $30,000. Finally, Aster Capital Management DIFC Ltd acquired a new position in UnitedHealth Group during the fourth quarter valued at approximately $30,000. 87.86% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several equities analysts recently weighed in on UNH shares. Barclays reduced their target price on shares of UnitedHealth Group from $642.00 to $560.00 and set an “overweight” rating on the stock in a report on Monday, April 21st. Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, April 22nd. HSBC restated a “hold” rating and issued a $490.00 price target on shares of UnitedHealth Group in a report on Tuesday, April 22nd. Truist Financial reduced their target price on shares of UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating on the stock in a research report on Monday, April 21st. Finally, JPMorgan Chase & Co. dropped their price target on shares of UnitedHealth Group from $652.00 to $525.00 and set an “overweight” rating on the stock in a research note on Thursday, April 24th. Four analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $596.86.
UnitedHealth Group Stock Performance
UNH stock opened at $311.23 on Wednesday. The firm has a market cap of $282.33 billion, a P/E ratio of 20.08, a P/E/G ratio of 1.37 and a beta of 0.56. The stock’s 50 day simple moving average is $482.53 and its 200 day simple moving average is $519.28. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $309.10 and a 12-month high of $630.73.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period last year, the firm posted $6.91 earnings per share. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 2.70%. UnitedHealth Group’s payout ratio is currently 35.18%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- Health Care Stocks Explained: Why You Might Want to Invest
- Archer Posts Surprise Q1 Beat, Sets Stage for 2025 Revenue Launch
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Joby Just Flew Two Aircraft at Once—Here’s Why It Matters
- Industrial Products Stocks Investing
- 4 Recent Earnings Winners Riding Fresh Momentum in May
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.